DXCM logo

DXCM
Dexcom Inc

10,069
Mkt Cap
$21.45B
Volume
10.94M
52W High
$93.25
52W Low
$54.11
PE Ratio
30.61
DXCM Fundamentals
Price
$55.09
Prev Close
$58.02
Open
$58.02
50D MA
$69.24
Beta
0.84
Avg. Volume
5.59M
EPS (Annual)
$1.42
P/B
7.87
Rev/Employee
$391,553.40
Loading...
Loading...
News
all
press releases
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM DexCom, Inc. Sued for Securities Law Violations - Contact Levi...
PR Newswire·10h ago
News Placeholder
More News
News Placeholder
DXCM Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm
DXCM Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses to Contact the Firm DXCM Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges DXCM Investors with Losses...
PR Newswire·14h ago
News Placeholder
Brooktree Capital Management Acquires 13,713 Shares of DexCom, Inc. $DXCM
Brooktree Capital Management raised its holdings in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 88.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·20h ago
News Placeholder
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall...
PR Newswire·23h ago
News Placeholder
Qubec Expands Access to Dexcom CGM under the Rgie de l'assurance maladie du Qubec (RAMQ)
Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Qubec government for its recent decision to expand coverage of Dexcom Continuous Glucose Monitoring (CGM) Systems...
Business Wire·1d ago
News Placeholder
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact The Gross Law Firm
Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact The Gross Law Firm Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact The...
PR Newswire·2d ago
News Placeholder
Here's Why DexCom (DXCM) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·4d ago
News Placeholder
Stockholder Alert: Robbins LLP Informs Investors of the Dexcom, Inc. Class Action Lawsuit
Stockholder Alert: Robbins LLP Informs Investors of the Dexcom, Inc. Class Action Lawsuit Stockholder Alert: Robbins LLP Informs Investors of the Dexcom, Inc. Class Action Lawsuit PR Newswire SAN...
PR Newswire·4d ago
News Placeholder
DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM) - Contact Kessler Topaz Meltzer & Check, LLP
DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM) - Contact Kessler Topaz Meltzer & Check, LLP DXCM Investor Alert: A Securities Fraud Class...
PR Newswire·6d ago
News Placeholder
DexCom Stock Falls Despite Q3 Earnings Beat, 2025 Revenue View Raised
DXCM posts double-digit Q3 growth and raises 2025 revenue outlook, but shares tumble despite strong CGM momentum and innovation updates.
Zacks·8d ago

Latest DXCM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.